T2	Disorder 86 99	lung diseases
T4	Subject 2290 2298	patients
T6	GGPs 1163 1167	CD25
T8	GGPs 1972 1976	IL-4
T12	Disorder 1625 1629	ABPA
T13	Disorder 2714 2726	eosinophilia
T18	GGPs 1980 1984	IL-5
T21	GGPs 565 574	TNF-alpha
T26	GGPs 551 555	IL-8
T28	GGPs 545 549	IL-6
T29	GGPs 2020 2028	cytokine
T31	Cell 1092 1095;1106 1113	CD4 T cells
T32	Gene_expression 1133 1143	expression
T33	GGPs 22 31	cytokines
T34	Subject 2527 2535	patients
T37	Subject 1630 1638	patients
T39	GGPs 1520 1528	cytokine
T40	Disorder 2450 2458	diseases
T42	GGPs 2096 2100	IL-5
T43	Cell 2655 2662	T cells
T44	GGPs 1005 1013	cytokine
T46	GGPs 362 370	cytokine
T48	GGPs 2605 2609	IL-5
T50	GGPs 1686 1690	IL-4
T54	GGPs 1561 1565	IL-5
T57	GGPs 533 537	IL-4
T62	Disorder 729 737;754 760	allergic asthma
T63	GGPs 1695 1699	IL-5
T66	Disorder 828 832	ABPA
T67	GGPs 602 609;619 632	soluble TNF receptors
T68	GGPs 539 543	IL-5
T69	Disorder 427 440	lung diseases
T74	Cell 2212 2218	T cell
T79	Subject 64 72	patients
T80	GGPs 2691 2695	IL-5
T87	Subject 715 723	patients
T90	GGPs 1869 1877	cytokine
T91	Cell 10 17	T cells
T92	GGPs 1215 1220	VLA-1
T96	Subject 1996 2003	patient
T98	Disorder 869 898	idiopathic pulmonary fibrosis
T100	Subject 1840 1848	patients
T103	Positive_regulation 199 209	regulation
T109	Subject 950 958	patients
T113	Disorder 1284 1297	lung diseases
T115	GGPs 1444 1452	cytokine
T117	Disorder 458 470	eosinophilia
T123	Subject 405 413	patients
T125	GGPs 516 525	IL-1 beta
T127	Cell 298 308	leukocytes
T128	GGPs 1170 1176	HLA-DR
T131	Anatomical_entity 2707 2713	tissue
T138	Disorder 742 760	nonallergic asthma
T140	Disorder 835 863	hypersensitivity pneumonitis
T141	Subject 1303 1311	patients
T142	Cell 1370 1373;1382 1389	CD4 T cells
T143	GGPs 2502 2506	IL-5
T144	Disorder 116 128	eosinophilia
T146	Disorder 762 785	eosinophilic  pneumonia
T153	GGPs 182 191	cytokines
T155	GGPs 1808 1816	cytokine
T160	GGPs 2227 2236	cytokines
E2	Gene_expression:T32 Theme:T159
E9	Positive_regulation:T103 Theme:E43
N3	Reference T2 UMLS:C0024115	Lung diseases
N7	Reference T4 UMLS:C0030705	Patients
N31	Reference T12 UMLS:C0004031	Aspergillosis, Allergic Bronchopulmonary
N38	Reference T13 UMLS:C0014457	Eosinophilia
N77	Reference T21 UMLS:C1456820	Tumor Necrosis Factor-alpha
N103	Reference T29 UMLS:C0079189	cytokine
N121	Reference T33 UMLS:C0079189	cytokine
N123	Reference T34 UMLS:C0030705	Patients
N130	Reference T37 UMLS:C0030705	Patients
N138	Reference T39 UMLS:C0079189	cytokine
N139	Reference T40 UMLS:C0012634	Disease
N150	Reference T43 UMLS:C0039194	T-Lymphocyte
N154	Reference T44 UMLS:C0079189	cytokine
N159	Reference T46 UMLS:C0079189	cytokine
N228	Reference T66 UMLS:C0004031	Aspergillosis, Allergic Bronchopulmonary
N233	Reference T67 UMLS:C0077503	Tumor Necrosis Factor Receptor
N238	Reference T69 UMLS:C0024115	Lung diseases
N257	Reference T74 UMLS:C0039194	T-Lymphocyte
N269	Reference T79 UMLS:C0030705	Patients
N303	Reference T90 UMLS:C0079189	cytokine
N304	Reference T91 UMLS:C0039194	T-Lymphocyte
N307	Reference T92 UMLS:C0254616	integrin alpha1beta1
N319	Reference T96 UMLS:C0030705	Patients
N325	Reference T98 UMLS:C1800706	Idiopathic Pulmonary Fibrosis
N330	Reference T100 UMLS:C0030705	Patients
N364	Reference T109 UMLS:C0030705	Patients
N374	Reference T113 UMLS:C0024115	Lung diseases
N382	Reference T115 UMLS:C0079189	cytokine
N388	Reference T117 UMLS:C0014457	Eosinophilia
N417	Reference T123 UMLS:C0030705	Patients
N424	Reference T125 UMLS:C0021753	Interleukin-1 beta
N427	Reference T127 UMLS:C0023516	Leukocytes
N430	Reference T128 UMLS:C0019764	HLA-DR Antigens
N445	Reference T131 UMLS:C0040300	Body tissue
N476	Reference T138 UMLS:C0155880	Intrinsic asthma
N485	Reference T140 UMLS:C0002390	Extrinsic allergic alveolitis
N487	Reference T141 UMLS:C0030705	Patients
N500	Reference T144 UMLS:C0014457	Eosinophilia
N508	Reference T146 UMLS:C1527407	Eosinophilic Pneumonia
N532	Reference T153 UMLS:C0079189	cytokine
N538	Reference T155 UMLS:C0079189	cytokine
N561	Reference T160 UMLS:C0079189	cytokine
T163	Disorder 938 949	sarcoidosis
N1	Reference T163 UMLS:C0036202	Sarcoidosis
T164	Disorder 1828 1839	sarcoidosis
N4	Reference T164 UMLS:C0036202	Sarcoidosis
N5	Reference T62 UMLS:C0155877	Allergic asthma
T165	Disorder 1608 1623	allergic asthma
N8	Reference T165 UMLS:C0155877	Allergic asthma
T95	Disorder 787 826	allergic bronchopulmonary aspergillosis
N9	Reference T95 UMLS:C0004031	Aspergillosis, Allergic Bronchopulmonary
T20	Cell 310 320	lymphocyte
N10	Reference T20 UMLS:C0024264	Lymphocyte
T53	Cell 1493 1508;1515 1519	T helper type 2 cell
N14	Reference T53 UMLS:C0242633	T-helper cell type 2
T76	Cell 1510 1513	Th2
N15	Reference T76 UMLS:C0242633	T-helper cell type 2
T78	Cell 2069 2077	Th2 cell
N17	Reference T78 UMLS:C0242633	T-helper cell type 2
N19	Reference T31 UMLS:C0039215	CD4 Positive T Lymphocytes
T10	Cell 1101 1113	CD8+ T cells
N20	Reference T10 UMLS:C0242629	CD8-Positive T-Lymphocytes
N21	Reference T142 UMLS:C0039215	CD4 Positive T Lymphocytes
T55	Cell 1378 1389	CD8 T cells
N25	Reference T55 UMLS:C0242629	CD8-Positive T-Lymphocytes
T71	Cell 1860 1868	Th1 cell
N24	Reference T71 UMLS:C0242632	T-helper cell type 1
T93	Cell 2062 2065;2073 2077	Th1 cell
N26	Reference T93 UMLS:C0242632	T-helper cell type 1
N29	Reference T26 UMLS:C0079633	Interleukin-8
N30	Reference T28 UMLS:C0021760	Interleukin-6
N32	Reference T57 UMLS:C0021758	Interleukin-4
T102	GGPs 1552 1556	IL-4
N33	Reference T102 UMLS:C0021758	Interleukin-4
N34	Reference T50 UMLS:C0021758	Interleukin-4
N22	Reference T8 UMLS:C0021758	Interleukin-4
T120	GGPs 2419 2423	IL-4
N35	Reference T120 UMLS:C0021758	Interleukin-4
T73	GGPs 557 563	GM-CSF
N36	Reference T73 UMLS:C0079460	Granulocyte-Macrophage Colony-Stimulating Factor
T148	GGPs 527 531	IL-2
N37	Reference T148 UMLS:C0021756	Interleukin-2
T156	GGPs 602 609;610 614;623 632	soluble IL-2 receptors
T167	GGPs 1587 1591	IL-2
N43	Reference T167 UMLS:C0021756	Interleukin-2
T168	GGPs 1755 1759	IL-2
N44	Reference T168 UMLS:C0021756	Interleukin-2
T169	GGPs 1931 1935	IL-2
N45	Reference T169 UMLS:C0021756	Interleukin-2
T170	GGPs 2102 2106	IL-2
N49	Reference T170 UMLS:C0021756	Interleukin-2
N51	Reference T68 UMLS:C0021759	Interleukin-5
N52	Reference T54 UMLS:C0021759	Interleukin-5
N54	Reference T63 UMLS:C0021759	Interleukin-5
N53	Reference T18 UMLS:C0021759	Interleukin-5
N55	Reference T42 UMLS:C0021759	Interleukin-5
N58	Reference T143 UMLS:C0021759	Interleukin-5
N60	Reference T48 UMLS:C0021759	Interleukin-5
N61	Reference T80 UMLS:C0021759	Interleukin-5
T41	GGPs 580 589	IFN-gamma
N63	Reference T41 UMLS:C0021745	Interferon Type II
T171	GGPs 1595 1604	IFN-gamma
N64	Reference T171 UMLS:C0021745	Interferon Type II
T172	GGPs 1764 1773	IFN-gamma
N65	Reference T172 UMLS:C0021745	Interferon Type II
T173	GGPs 1940 1949	IFN-gamma
N66	Reference T173 UMLS:C0021745	Interferon Type II
T174	GGPs 2112 2121	IFN-gamma
N67	Reference T174 UMLS:C0021745	Interferon Type II
N39	Reference T156 UMLS:C0034819	Interleukin 2 Receptor
N16	Reference T6 UMLS:C0007507	Antigens, CD25
T159	GGPs 1147 1161	IL-2 receptors
N41	Reference T159 UMLS:C0034819	Interleukin 2 Receptor
T11	GGPs 1186 1214	very late activation antigen
N27	Reference T11 UMLS:C0034847	Receptors, Very Late Antigen
T5	GGPs 2249 2258	receptors
T16	GGPs 2486 2489	IgE
N11	Reference T16 UMLS:C0020846	Immunoglobulin E
N12	Reference T5 UMLS:C0597357	receptor
T47	Anatomical_entity 390 399	BAL fluid
N13	Reference T47 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T86	Anatomical_entity 900 909	BAL fluid
N28	Reference T86 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T97	Anatomical_entity 1472 1481	BAL fluid
N46	Reference T97 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T15	Anatomical_entity 650 684	bronchoalveolar lavage (BAL) fluid
N42	Reference T15 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T64	Anatomical_entity 2168 2177	BAL fluid
N57	Reference T64 UMLS:C0006279	Bronchoalveolar Lavage Fluid
T75	Subject 2004 2010	groups
N62	Reference T75 UMLS:C1257890	Population Group
T99	Subject 991 999	controls
N68	Reference T99 UMLS:C0009932	Control Groups
T104	Subject 922 933	individuals
T106	Subject 1411 1422	individuals
T112	Subject 2320 2331	individuals
N71	Reference T112 UMLS:C0237401	Individual
R1	Subject_Disorder Arg1:T123 Arg2:T69	
T17	Subject 715 723	patients
R2	Subject_Disorder Arg1:T17 Arg2:T62	
R3	Subject_Disorder Arg1:T87 Arg2:T138	
T116	Subject 715 723	patients
T119	Subject 715 723	patients
T129	Subject 715 723	patients
R4	Subject_Disorder Arg1:T129 Arg2:T146	
R5	Subject_Disorder Arg1:T119 Arg2:T95	
R6	Subject_Disorder Arg1:T116 Arg2:T140	
T134	Subject 715 723	patients
R7	Subject_Disorder Arg1:T134 Arg2:T98	
R8	Subject_Disorder Arg1:T109 Arg2:T163	
R9	Subject_Disorder Arg1:T37 Arg2:T12	
R10	Subject_Disorder Arg1:T100 Arg2:T164	
R11	Subject_Disorder Arg1:T79 Arg2:T2	
E5	Gene_expression:T32 Theme:T92
E8	Gene_expression:T32 Theme:T128
T23	Gene_expression 1676 1682	levels
E11	Gene_expression:T23 Theme:T63
N80	Reference E11 UMLS:C1519614	Genetic Translation Process
E12	Gene_expression:T23 Theme:T50
N81	Reference E12 UMLS:C1519614	Genetic Translation Process
T85	Gene_expression 2276 2282	levels
E13	Gene_expression:T85 Theme:T5
N82	Reference E13 UMLS:C1519614	Genetic Translation Process
T135	Gene_expression 2276 2282	levels
E14	Gene_expression:T135 Theme:T160
N85	Reference E14 UMLS:C1519614	Genetic Translation Process
T136	Gene_expression 1577 1583	levels
E15	Gene_expression:T136 Theme:T54 disorder:T165
N87	Reference E15 UMLS:C1519614	Genetic Translation Process
E16	Gene_expression:T136 Theme:T102 disorder:T165
N88	Reference E16 UMLS:C1519614	Genetic Translation Process
T139	Gene_expression 1737 1751	concentrations
E19	Gene_expression:T139 Theme:T172
N91	Reference E19 UMLS:C1519614	Genetic Translation Process
E17	Gene_expression:T139 Theme:T168
N89	Reference E17 UMLS:C1519614	Genetic Translation Process
T110	Gene_expression 1913 1927	concentrations
E18	Gene_expression:T110 Theme:T173
N90	Reference E18 UMLS:C1519614	Genetic Translation Process
E20	Gene_expression:T110 Theme:T169
N93	Reference E20 UMLS:C1519614	Genetic Translation Process
T49	Gene_expression 2424 2430	levels
E21	Gene_expression:T49 Theme:T120
N95	Reference E21 UMLS:C1519614	Genetic Translation Process
T137	Gene_expression 2490 2500	production
E22	Gene_expression:T137 Theme:T16
N96	Reference E22 UMLS:C1519614	Genetic Translation Process
T7	Anatomical_entity 35 58	bronchoalveolar lavages
T25	Anatomical_entity 1001 1004	BAL
N56	Reference T25 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N18	Reference T7 UMLS:C0006279	Bronchoalveolar Lavage Fluid
N69	Reference T104 UMLS:C0027361	Persons
N70	Reference T106 UMLS:C0027361	Persons
N74	Reference T134 UMLS:C0030705	Patients
N50	Reference T116 UMLS:C0030705	Patients
N72	Reference T119 UMLS:C0030705	Patients
N73	Reference T129 UMLS:C0030705	Patients
N48	Reference T17 UMLS:C0030705	Patients
N47	Reference T87 UMLS:C0030705	Patients
N76	Reference E5 UMLS:C1519614	Genetic Translation Process
N78	Reference E8 UMLS:C1519614	Genetic Translation Process
N75	Reference E2 UMLS:C1519614	Genetic Translation Process
T19	Positive_regulation 0 9	Activated
E1	Positive_regulation:T19 Theme:T91 atLoc:T7
N86	Reference E1 UMLS:C1879547	Activation action
T84	Positive_regulation 1543 1551	elevated
E4	Positive_regulation:T84 Theme:E15 Cue:T182 Cue2:T181
N97	Reference E4 UMLS:C1879547	Activation action
T147	Positive_regulation 1728 1736	elevated
E23	Positive_regulation:T147 Theme:E17 disorder:T12
N98	Reference E23 UMLS:C1879547	Activation action
T151	Positive_regulation 2511 2519	elevated
E24	Positive_regulation:T151 Theme:T143 disorder:T65
N99	Reference E24 UMLS:C1879547	Activation action
T152	Positive_regulation 1666 1675	increased
E25	Positive_regulation:T152 Theme:E12 disorder:T12 Cue:T183
N100	Reference E25 UMLS:C1879547	Activation action
T157	Positive_regulation 1903 1912	increased
E26	Positive_regulation:T157 Theme:E20 Cue:T184 disorder:T164 Cue2:T185
N101	Reference E26 UMLS:C1879547	Activation action
T158	Positive_regulation 2153 2162	increased
E27	Positive_regulation:T158 Theme:T174 Cue:T186
N102	Reference E27 UMLS:C1879547	Activation action
T161	Positive_regulation 2266 2275	increased
E28	Positive_regulation:T161 Theme:E14 Cue:T178 Cue2:T187
N106	Reference E28 UMLS:C1879547	Activation action
T166	Positive_regulation 2409 2418	increased
E29	Positive_regulation:T166 Theme:E21 disorder:T40 Cue:T191
N107	Reference E29 UMLS:C1879547	Activation action
T175	Positive_regulation 2476 2485	increased
E30	Positive_regulation:T175 Theme:E22
N109	Reference E30 UMLS:C1879547	Activation action
T177	Positive_regulation 1339 1348	increased
E32	Positive_regulation:T177 Theme:E34 Cue:T180
R12	member_of Arg1:T75 Arg2:T96	
T58	Positive_regulation 1360 1369	activated
E33	Positive_regulation:T58 Theme:T55
E34	Positive_regulation:T58 Theme:T142
E35	Positive_regulation:T157 Theme:E18 Cue:T184 Cue2:T185 disorder:T164
N111	Reference E35 UMLS:C1879547	Activation action
E36	Positive_regulation:T158 Theme:T170 Cue:T186
N112	Reference E36 UMLS:C1879547	Activation action
E37	Positive_regulation:T158 Theme:T42 Cue:T186
N113	Reference E37 UMLS:C1879547	Activation action
T88	Positive_regulation 2645 2654	activated
E38	Positive_regulation:T88 Theme:T43
N114	Reference E38 UMLS:C1879547	Activation action
T3	Positive_regulation 2699 2706	causing
E39	Positive_regulation:T3 Theme:T13
N6	Reference E39 UMLS:C1879547	Activation action
N115	Reference E9 UMLS:C1879547	Activation action
T179	Regulation 160 177	an important role
E42	Regulation:T179 Cause:T153 Theme:E9 Cue:T121
T94	Biological_process 213 238	eosinophilic inflammation
E43	Biological_process:T94 
T52	Regulation 2682 2686	role
E44	Regulation:T52 Cause:T80 Theme:E39 Cue:T192
T27	Biological_process 2362 2384	inflammatory responses
E45	Biological_process:T27 Cue:T188 Cue2:T189
E46	Positive_regulation:T152 Theme:E11 disorder:T12 Cue:T183
N92	Reference E46 UMLS:C1879547	Activation action
E47	Positive_regulation:T147 Theme:E19 disorder:T12
N122	Reference E47 UMLS:C1879547	Activation action
T45	Positive_regulation 2266 2275	increased
E48	Positive_regulation:T45 Theme:E13 Cue:T178 Cue2:T187
N124	Reference E48 UMLS:C1879547	Activation action
T118	Localization 1044 1063	cellular infiltrate
E49	Localization:T118 
T60	Cellular_process 2078 2086	response
E3	Cellular_process:T60 Theme:T93
N129	Reference E3 UMLS:C1817908	Cellular Immune Response
T65	Disorder 2541 2573	increased numbers of eosinophils
N131	Reference T65 UMLS:C0014457	Eosinophilia
R15	Subject_Disorder Arg1:T34 Arg2:T65	
R16	Disorder_association Arg1:T2 Arg2:T144	
R17	Disorder_association Arg1:T69 Arg2:T117	
T24	Positive_regulation 1339 1348	increased
E6	Positive_regulation:T24 Theme:E33 Cue:T180
T38	Positive_regulation 1072 1082	activation
E7	Positive_regulation:T38 Theme:T10
N84	Reference E7 UMLS:C1879547	Activation action
E31	Positive_regulation:T38 Theme:T31
N110	Reference E31 UMLS:C1879547	Activation action
T70	Positive_regulation 336 346	activation
E10	Positive_regulation:T70 Theme:T20 Cue:T176
N116	Reference E10 UMLS:C1879547	Activation action
T81	Positive_regulation 336 346	activation
E40	Positive_regulation:T81 Theme:T127 Cue:T176
N117	Reference E40 UMLS:C1879547	Activation action
T83	Measurement 2618 2639	number of eosinophils
N132	Reference T83 UMLS:C0200638	Eosinophil count procedure
N94	Reference E45 UMLS:C1155266	inflammatory response
N119	Reference E43 UMLS:C0333390	Chronic eosinophilic inflammation
T36	Disorder 213 238	eosinophilic inflammation
N127	Reference T36 UMLS:C0333390	Chronic eosinophilic inflammation
R18	member_of Arg1:T92 Arg2:T11	
T101	Correlation 2459 2472	characterized
E51	Correlation:T101 Theme:T40 Theme2:E30
N133	Reference E51 UMLS:C0332281	Associated with
T105	Correlation 2585 2596	correlation
E52	Correlation:T105 Theme:T48 Theme2:T83 Theme3:E38
N134	Reference E52 UMLS:C0332281	Associated with
E53	Positive_regulation:T84 Theme:E16 Cue:T182 Cue2:T181
N135	Reference E53 UMLS:C1879547	Activation action
T114	Correlation 1233 1247	characteristic
E54	Correlation:T114 Theme2:T113 Theme:E56
N136	Reference E54 UMLS:C0332281	Associated with
N126	Reference E49 UMLS:C1692321	Cellular infiltrate
R19	part_of Arg1:T127 Arg2:T47	
R20	part_of Arg1:T20 Arg2:T47	
E41	Cellular_process:T60 Theme:T78
N128	Reference E41 UMLS:C1817908	Cellular Immune Response
T59	Artificial_process 637 649	concentrated
E55	Artificial_process:T59 Theme:T15
N140	Reference E55 UMLS:C2003864	Concentrate (activity)
T132	Speculation_cue 1117 1125	measured
T149	Anatomical_entity 900 909	BAL fluid
N145	Reference T149 UMLS:C0006279	Bronchoalveolar Lavage Fluid
R14	part_of Arg1:T86 Arg2:T104	
R21	part_of Arg1:T149 Arg2:T109	
T178	Speculation_cue 2178 2186	analysis
R22	part_of Arg1:T7 Arg2:T79	
R23	part_of Arg1:T47 Arg2:T123	
T121	Speculation_cue 151 159	suggests
A1	Speculated E42
T176	Speculation_cue 264 276	investigated
A2	Speculated E40
A3	Speculated E10
R24	part_of Arg1:T15 Arg2:T116	
R25	part_of Arg1:T15 Arg2:T134	
R26	part_of Arg1:T15 Arg2:T119	
R27	part_of Arg1:T15 Arg2:T17	
R28	part_of Arg1:T15 Arg2:T129	
R29	part_of Arg1:T15 Arg2:T87	
T180	Speculation_cue 1312 1324	demonstrated
T181	Speculation_cue 1482 1490	revealed
T182	Speculation_cue 1428 1436	analysis
A6	Speculated E53
A7	Speculated E4
T183	Speculation_cue 1639 1651	demonstrated
A8	Speculated E46
A9	Speculated E25
T184	Speculation_cue 1792 1800	analysis
T185	Speculation_cue 1849 1857	revealed
A10	Speculated E26
A11	Speculated E35
T186	Speculation_cue 2127 2132	found
A12	Speculated E37
A13	Speculated E36
A14	Speculated E27
T187	Speculation_cue 2259 2265	showed
T188	Speculation_cue 2336 2339	may
T189	Speculation_cue 2340 2349	represent
A15	Speculated E28
A16	Speculated E48
A17	Speculated E45
T191	Speculation_cue 2436 2441	found
A18	Speculated E29
A19	Speculated E24
T192	Speculation_cue 2671 2679	supports
A20	Speculated E44
T145	Localization 1258 1268	infiltrate
E56	Localization:T145 Theme:T190
N141	Reference E56 UMLS:C1692321	Cellular infiltrate
T190	Cell 1248 1257	leukocyte
N144	Reference T190 UMLS:C0023516	Leukocytes
N2	Reference E34 UMLS:C1879547	Activation action
N143	Reference E33 UMLS:C1879547	Activation action
N146	Reference E32 UMLS:C1879547	Activation action
N147	Reference E6 UMLS:C1879547	Activation action
N118	Reference E42 UMLS:C1327622	Regulation of biological process
N120	Reference E44 UMLS:C1327622	Regulation of biological process
